Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

BACKGROUND: The loss of chloroquine (CQ) effectiveness has led to its withdrawal from national policies as a first-line treatment for uncomplicated malaria in several endemic countries, such as the Democratic Republic of Congo (DRC). The K76T mutation on the pfcrt gene has been identified as a marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Situakibanza, Hippolyte N. T., Likwela, Joris L., De Mol, Patrick, Okitolonda, Emile W., Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085146/
https://www.ncbi.nlm.nih.gov/pubmed/32197607
http://dx.doi.org/10.1186/s12936-020-03192-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085146/
https://www.ncbi.nlm.nih.gov/pubmed/32197607
http://dx.doi.org/10.1186/s12936-020-03192-x

Ejemplares similares